Direct Oral Anticoagulants

  • Thomas G. DeLougheryEmail author


This chapter reviews the new direct oral anticoagulants – thrombin and Xa inhibitors. The specific drugs are reviewed as well as the specific indications – prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs in are reviewed.


Apixaban Betrixaban Dabigatran Edoxaban Rivaroxaban 

Suggested Reading

  1. Barnes GD, Kurtz B. Direct oral anticoagulants: unique properties and practical approaches to management. Heart. 2016;102(20):1620–6.CrossRefGoogle Scholar
  2. Barr D, Epps QJ. Direct oral anticoagulants: a review of common medication errors. J Thromb Thrombolysis. 2019;47(1):146–54.CrossRefGoogle Scholar
  3. López-López JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savović J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ. 2017;359:j5058.CrossRefGoogle Scholar
  4. Samuelson BT, Cuker A, Siegal DM, Crowther M, Garcia DA. Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review. Chest. 2017;151(1):127–38.CrossRefGoogle Scholar
  5. van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124(12):1968–75.CrossRefGoogle Scholar
  6. Weber J, Olyaei A, Shatzel J. The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: a review of the literature. Eur J Haematol. 2019;102(4):312–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Hematology/Medical Oncology, Department of Medicine, Pathology, and PediatricsOregon Health & Sciences UniversityPortlandUSA

Personalised recommendations